Circulating Tumor Cell (CTC) Diagnostics: Technologies and Global Markets

Mar 2022| PHM153C| BCC Publishing
Sample Report

Report Highlights

The global market for circulating tumor cells (CTC) diagnostics is estimated to increase from $8.8 billion in 2021 to $15.2 billion by 2026, at a compound annual growth rate (CAGR) of 15.6% during the forecast period of 2021-2026.

Report Includes

  • 24 data tables and 49 additional tables
  • An up-to-date review and analysis of the global markets for circulating tumor cell (CTC) diagnostics
  • Analyses of the global market trends, with data from 2019-2021, and projections of compound annual growth rates (CAGRs) through 2026
  • Highlights of the upcoming market opportunities in the CTC diagnostics industry, and areas of focus to forecast this market into various segments and sub-segments
  • Evaluation and forecast the global CTC diagnostics market size, forecasted growth trends, and corresponding market share analysis by cancer type, technology, application, and region
  • In-depth information concerning market drivers and challenges, latest technologies, breakthrough innovations, costs and benefits of CTC enrichment techniques, regulatory concerns, and clinical trials
  • Statistical information (facts and figures) on cancer incidence and prevalence, global cancer related deaths, and new cases of cancer by type in the United States
  • Review of recent industry trends, value chain analysis, competitive landscape, and COVID-19 implications within the marketplace
  • Descriptive company profiles of the leading global players, including Bio-Techne Corp., Biocept Inc., Greiner Bio-One International GmbH, Precision Medicine Group LLC, Menarini Silicon Biosystems, and Qiagen N.V.

Report Scope

The scope of this study involves clinical testing, prognostic and monitoring markets for CTCs in cancer. The report also includes the clinical research segment as well as currently approved CTC tests and their markets. The regulatory environment, current technologies, new technologies, cancer incidence, market projections and market share, along with the latest trends and new developments in this area, are included to support the clinical testing market.

Based on cancer type, the market for circulating tumor cells diagnostics is segmented into breast cancer, colorectal cancer and prostate cancer.

Based on technology, the market for circulating tumor cells diagnostics is segmented into CTC enrichment and detection, CTC direct detection and CTC analysis.

Based on application, the market for circulating tumor cells diagnostics is segmented into clinical/liquid biopsy and research.

The report discusses the qualitative and quantitative factors influencing market growth. Market drivers, restraints and opportunities are discussed in the report.

This report discusses some of the major drivers and restraints in the market for circulating tumor cells diagnostics, and it surveys the competitive landscape as well as the key players’ strategies and performances. The discussion is focused on the major market players, trends in product launches, collaborations, and mergers and acquisitions. The report also includes company profiles of major vendors that include a company overview, key product offerings, financial statistics and recent developments. The report provides insights on market shares and upcoming regional demand for circulating tumor cells diagnostics.

Some of the major market players discussed in the report are Qiagen N.V., Biocept Inc., Greiner Bio One International GmbH, Precision Medicine Group LLC and Menarini Silicon Biosystems. For market estimates, data have been provided for the 2020 as the base year, with forecasts for 2021 through 2026. Projected and forecasted revenue values are in constant U.S. dollars that have not been adjusted for inflation.

Analyst Credentials

BCC Publishing Staff comprises expert analysts who are skilled in conducting primary research, secondary research and data analysis and have decades of combined experience covering a wide range of industries, including healthcare, advanced materials and emerging technologies. Collectively, the team represents a diverse set of educational achievements with individual graduate work completed in fields such as microbiology, electrical engineering, business administration and surgery, among others.

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesPrice Member Price
Full Report: Circulating Tumor Cell (CTC) Diagnostics: Technologies and Global Markets157 $5,500 Free
Chapter- 1: Introduction9Free DownloadFree
Chapter- 2: Summary and Highlights2$250Free
Chapter- 3: Market and Technology Background25$881Free
Chapter- 4: CTC Diagnostic Technologies30$1,058Free
Chapter- 5: Impact of COVID-19 on the CTC Diagnostics Market2$71Free
Chapter- 6: Market Dynamics6$212Free
Chapter- 7: Market Breakdown by Cancer Type11$388Free
Chapter- 8: Market Breakdown by Technology10$353Free
Chapter- 9: Market Breakdown by Application6$212Free
Chapter- 10: Market Breakdown by Region27$952Free
Chapter- 11: Company Profiles28$987Free
Chapter- 12: Appendix: List of Acronyms1$35Free
Published - May-2018| Analyst - Usha Nagavarapu| Code - PHM153B

Report Highlights

The global market for circulating tumor cell technology will grow from nearly $4.6 billion in 2017 to around $10.3 billion by 2022 with a compound annual growth rate (CAGR) of 17.6% for the period of 2017-2022.

Report Includes

  • 118 Tables
  • An overview of the global market for cancer diagnostics, based on circulating tumor cells, which are used to increase understanding of tumor cell biology and metastatic cancer as a disease.
  • Analyses of global market trends, with data from 2016, estimates from 2017, and projections of compound annual growth rates (CAGRs) through 2022.
  • Discussions covering the advantages and disadvantages of CTC enrichment techniques.
  • Estimations of cancer incidence, cancer deaths, new cases by type in the United States, and breast cancer statistics and facts.
  • Examination of growth opportunities and drivers in the CTC market and recent breakthroughs in research, along with a patent analysis.
  • Information about the clinical testing, prognostic, and monitoring markets for CTCs in cancer.
  • Coverage of approved CTC tests and their markets, and the regulatory environment.
  • Company profiles of major players across various product categories, including Cytotrack, Menarini-Silicon Biosystems And A. Menarini Diagnostics (Veridex Llc), Greiner Bio-One Gmbh, Cynvenio Biosystems Inc., Biofluidica Microtechnologies Llc and Advanced Cell Diagnostics
Published - Jan-2014| Analyst - Usha Nagavarapu| Code - PHM153A

Report Highlights

The global market for circulating tumor cell (CTC) technology reached nearly $2.8 billion in 2012 and $3.7 billion in 2013. This market is estimated to reach nearly $8.9 billion by 2018, demonstrating a compound annual growth rate (CAGR) of 18.9% for the five-year period, 2013 to 2018.

Report Includes

  • An overview of the global market for cancer diagnostics based on circulating tumor cells, which are used to increase understanding of tumor cell biology and metastatic cancer as a disease.
  • Analyses of global market trends, with data from 2012 and 2013, and projections of compound annual growth rates for the period of 2013 to 2018.
  • Discussion of the advantages and disadvantages of CTC enrichment techniques.
  • Estimations of cancer incidence, cancer deaths, new cases by type in the United States, and breast cancer statistics and facts.
  • Examination of growth opportunities and drivers in the CTC market and recent breakthroughs in research, along with a patent analysis.

Circulating Tumor Cell (CTC) Diagnostics: Technologies and Global Markets

Single User License: $5500

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research.?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

RELATED REPORTS